Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - NYSE:IMAX - CA45245E1097 - Common Stock

31.96 USD
-0.35 (-1.08%)
Last: 9/19/2025, 8:19:15 PM
31.96 USD
0 (0%)
After Hours: 9/19/2025, 8:19:15 PM
Fundamental Rating

5

IMAX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 80 industry peers in the Entertainment industry. IMAX has only an average score on both its financial health and profitability. IMAX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IMAX was profitable.
IMAX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
IMAX had a positive operating cash flow in 4 of the past 5 years.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.77%, IMAX is in the better half of the industry, outperforming 78.75% of the companies in the same industry.
IMAX's Return On Equity of 10.23% is fine compared to the rest of the industry. IMAX outperforms 77.50% of its industry peers.
IMAX has a Return On Invested Capital of 6.88%. This is in the better half of the industry: IMAX outperforms 78.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 9.25%.
The last Return On Invested Capital (6.88%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.77%
ROE 10.23%
ROIC 6.88%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin of IMAX (9.04%) is better than 85.00% of its industry peers.
IMAX's Profit Margin has declined in the last couple of years.
IMAX has a better Operating Margin (18.00%) than 91.25% of its industry peers.
In the last couple of years the Operating Margin of IMAX has declined.
The Gross Margin of IMAX (56.88%) is better than 66.25% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18%
PM (TTM) 9.04%
GM 56.88%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

IMAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IMAX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
The debt/assets ratio for IMAX is higher compared to a year ago.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 2.37. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.37, IMAX is doing good in the industry, outperforming 67.50% of the companies in the same industry.
The Debt to FCF ratio of IMAX is 4.75, which is a neutral value as it means it would take IMAX, 4.75 years of fcf income to pay off all of its debts.
IMAX's Debt to FCF ratio of 4.75 is fine compared to the rest of the industry. IMAX outperforms 66.25% of its industry peers.
IMAX has a Debt/Equity ratio of 0.87. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
IMAX has a Debt to Equity ratio of 0.87. This is in the lower half of the industry: IMAX underperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 4.75
Altman-Z 2.37
ROIC/WACC0.94
WACC7.29%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.33 indicates that IMAX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.33, IMAX is in the better half of the industry, outperforming 76.25% of the companies in the same industry.
IMAX has a Quick Ratio of 2.02. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of IMAX (2.02) is better than 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 2.02
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.82% over the past year.
IMAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.17% yearly.
IMAX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.25%.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%

3.2 Future

Based on estimates for the next years, IMAX will show a very strong growth in Earnings Per Share. The EPS will grow by 24.18% on average per year.
The Revenue is expected to grow by 6.72% on average over the next years.
EPS Next Y32.98%
EPS Next 2Y26.22%
EPS Next 3Y18.66%
EPS Next 5Y24.18%
Revenue Next Year11.3%
Revenue Next 2Y8.43%
Revenue Next 3Y6.72%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.64, the valuation of IMAX can be described as expensive.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than the industry average as 78.75% of the companies are valued more expensively.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 21.12, IMAX is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 82.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, IMAX is valued at the same level.
Industry RankSector Rank
PE 31.64
Fwd PE 21.12
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

IMAX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 70.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than 78.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.35
EV/EBITDA 15.24
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
IMAX's earnings are expected to grow with 18.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y26.22%
EPS Next 3Y18.66%

0

5. Dividend

5.1 Amount

No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (9/19/2025, 8:19:15 PM)

After market: 31.96 0 (0%)

31.96

-0.35 (-1.08%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners91.41%
Inst Owner Change0.92%
Ins Owners19.45%
Ins Owner Change-0.43%
Market Cap1.72B
Analysts80
Price Target34.49 (7.92%)
Short Float %14.84%
Short Ratio5.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.07%
Min EPS beat(2)11.91%
Max EPS beat(2)20.24%
EPS beat(4)3
Avg EPS beat(4)19.46%
Min EPS beat(4)-6.42%
Max EPS beat(4)52.13%
EPS beat(8)7
Avg EPS beat(8)69.57%
EPS beat(12)9
Avg EPS beat(12)28.75%
EPS beat(16)11
Avg EPS beat(16)16.57%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)1.04%
Revenue beat(4)1
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.35%
Revenue beat(12)6
Avg Revenue beat(12)1.29%
Revenue beat(16)7
Avg Revenue beat(16)2.04%
PT rev (1m)0.81%
PT rev (3m)8.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.55%
EPS NY rev (1m)8.34%
EPS NY rev (3m)9.26%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 31.64
Fwd PE 21.12
P/S 4.74
P/FCF 29.35
P/OCF 22.34
P/B 5.36
P/tB 7.71
EV/EBITDA 15.24
EPS(TTM)1.01
EY3.16%
EPS(NY)1.51
Fwd EY4.74%
FCF(TTM)1.09
FCFY3.41%
OCF(TTM)1.43
OCFY4.48%
SpS6.74
BVpS5.96
TBVpS4.15
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 10.23%
ROCE 8.68%
ROIC 6.88%
ROICexc 8.05%
ROICexgc 11.79%
OM 18%
PM (TTM) 9.04%
GM 56.88%
FCFM 16.16%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexcg growth 3Y113.18%
ROICexcg growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 4.75
Debt/EBITDA 2.22
Cap/Depr 30.7%
Cap/Sales 5.07%
Interest Coverage 250
Cash Conversion 61.51%
Profit Quality 178.66%
Current Ratio 2.33
Quick Ratio 2.02
Altman-Z 2.37
F-Score7
WACC7.29%
ROIC/WACC0.94
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
EPS Next Y32.98%
EPS Next 2Y26.22%
EPS Next 3Y18.66%
EPS Next 5Y24.18%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%
Revenue Next Year11.3%
Revenue Next 2Y8.43%
Revenue Next 3Y6.72%
Revenue Next 5YN/A
EBIT growth 1Y52.22%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year234.78%
EBIT Next 3Y52.46%
EBIT Next 5Y33.94%
FCF growth 1Y63.61%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y58.66%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%